suprefact buserelin acetate 1.05 mg/ml solution for injection vial
sanofi-aventis australia pty ltd - buserelin acetate -
fertigest 0,004 mg/ml inj. sol. i.m./s.c. vial
vetpharma animal health s.l. - buserelin acetate 4,2 µg/ml - eq. buserelin 4 µg/ml - solution for injection - 0,004 mg/ml - buserelin acetate 4.2 µg/ml - buserelin - cattle; horse; pig; rabbit
porceptal 4 µg/ml inj. sol. i.m./s.c. vial
intervet international b.v. - buserelin acetate 4,2 µg/ml - eq. buserelin 4 µg/ml - solution for injection - 4 µg/ml - buserelin acetate 4.2 µg/ml - buserelin - pig
veterelin 0,004 mg/ml inj. sol. i.v./i.m./s.c. vial
laboratorios calier s.a. - buserelin acetate 4,2 µg/ml - eq. buserelin 4 µg/ml - solution for injection - 0,004 mg/ml - buserelin acetate 4.2 µg/ml - buserelin - cattle; horse; rabbit; pig
busol 0,004 mg/ml inj. sol. i.v./s.c./i.m. vial
t.p. whelehan son & co. ltd. - buserelin acetate 0,004 mg/ml - solution for injection - 0,004 mg/ml - buserelin acetate 0.004 mg/ml - buserelin - horse; cattle; rabbit
receptal 4,2 µg/ml inj. sol. i.m./i.v./s.c. vial
intervet international - buserelin acetate 4.2 µg/ml - solution for injection - 4,2 µg/ml - buserelin acetate 4.2 µg/ml - buserelin - cattle; horse; rabbit; pig
busol 0.004 mg/ml solution for injection for cattle, horses, rabbits
t.p. whelehan son & co. ltd., - buserelin acetate - solution for injection - 0.004 milligram(s)/millilitre - buserelin - cattle, horses, rabbits - hormone
suprefact
sanofi-aventis new zealand limited - buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin - solution for injection - 1 mg/ml - active: buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin excipient: benzyl alcohol monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection - for the treatment of endometriosis not primarily requiring surgical treatment. pituitary desensitisation in preparation for ovulation induction regimens using gonadotrophins.
buserelin acetate
intervet australia pty limited - buserelin acetate - unknown - buserelin acetate hormone-gonadotrophin active 0.0 - active constituent
suprefact depot 3-months
sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).